Infinity Pharmaceuticals | INFI - Le Chiffre D'Affaires De Vente





Ventes Changement Date
AbbVie USD 16.62B 840M 2025-12
Alterity Therapeutics Limited AUD 596.04K 584.66K 2025-12
Amgen USD 9.9B 340M 2025-12
AstraZeneca USD 15.5B 313M 2025-12
Bristol-Myers Squibb USD 12.5B 300M 2025-12
Cipla INR 75.18B 710M 2025-12
Clal Biotechnology ILS 3.41M 2M 2022-12
Compugen USD 67.33M 65.44M 2025-12
CSL USD 8.33B 4.79B 2025-12
Eisai JPY 219.94B 22.58B 2025-12
Eli Lilly USD 19.3B 1.7B 2025-12
Gilead Sciences USD 7.93B 130M 2025-12
GlaxoSmithKline GBP 8.62B 73M 2025-12
Grifols EUR 2.34B 33.3M 2026-03
Incyte USD 1.51B 140M 2025-12
Infinity Pharmaceuticals USD 583K 148K 2023-06
Ionis Pharmaceuticals USD 203M 46M 2025-12
J&J USD 24.1B 500M 2026-03
Novartis USD 13.86B 50M 2025-12
Pfizer USD 17.58B 880M 2025-12
Plus Therapeutics USD 1.37M 30K 2025-12
Roche Holding CHF 15.65B 274.5M 2025-12
TG Therapeutics USD 192.57M 30.87M 2025-12